Updated 08:05 GMT, 20 Nov 2026 SPX 7,175.83 -2.02% NDX 26,517.05 -2.21% VIX 28.44 +15.80% GOLD 3,574.90 -3.00% CL 82.63 -0.70% BTC 61,735.58 -0.27%
NAS100 26,517 −2.21% S&P 7,176 −2.02% GOLD $3,575 −3.00% BTC $61,736 −0.27% VIX 28.44 +15.80% latest tape · as of 08:05 UTC
The Screen · Consumer Cyclical · Restaurants

Starbucks logoStarbucks

SBUX · a US exchange · USD · Market cap $125.4B · 381,000 employees

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of coffee internationally.

FAIL · Does not pass the screen
104.47 USD

Price as of 19 Nov 2026Daily close, not a live quote

Screened 2026-11-19 · the tape above runs as of 08:05 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price104.47 USD at the 19 Nov 2026 close
  • Our value readFair vs our fair value, as of 19 Nov 2026
  • Our regime readMarkup, as of 15 Nov 2026
  • Ethical screenDoes not pass
  • OptionsOpen interest leans slightly to calls (put/call 0.90)
  • Last reviewed19 Nov 2026 (1 day ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: $73.80 to $110.65, base estimate $96.22 (screen dated 2026-11-19).

Current read
Markup ?
Fair · screened 2026-11-19
  • Trend Markup
  • Insiders insiders sold, $245,190, latest filing 2026-11-05
  • Positioning political selling, disclosed 2026-10-02
  • Options put/call open interest 0.90, read 2026-11-18
  • Ethical does not pass the values gate
Price104.47 USD
Fair value96.22
Ethical score10.0/100
Value readFairas of 19 Nov 2026
Our investment reviews on this name
2026-11-12Read Markup109.89-4.9% to today Accumulation gives way to Markup after a 13% rise in 3 weeks
2026-10-22Read Accumulation96.88+7.8% to today ✓Markdown gives way to Accumulation
2026-10-02Read Markdown94.86+10.1% to today Accumulation gives way to Markdown after a 9% slide in 5 weeks
2026-08-29Read Accumulation103.99+0.5% to today ✓Markup gives way to Accumulation after a 9% rise in 8 weeks

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its markup label.

Starbucks holds its Markup at $104.47. The statistical read favours the sellers, held for 110 days.

As held on the ledger · 2026-11-19
PhaseMarkup
Quantitative stateThe statistical read favours the sellers, held for 110 days
Price at the screen$104.47
Valuation49.75 trailing · 29.52 forward price to earnings
Values screenFAIL · score 10.0
Beta1.01
The Workings

Five Screens: SBUX's Results

FAIL. Debt ratio

TestFigureLimitStatus
Business activity Permissible Permissible core business Pass
Debt load 83.11% Below 33% Fail
Interest-bearing cash 0.77% Below 33% Pass
Receivables 14.05% Below 49% Pass
Revenue purity 0.30% Below 5% Pass

Definitions, sources and threshold rules: ticker values-screen methodology.

The Ethical Read

Why It Falls Short, in Plain English

Starbucks's business is in a permissible area, but its interest-bearing debt is about 83% of the company, well over the ~33% line, so it does not pass on the financial screens.

Read as at 2026-11-19. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when SBUX's ethical verdict changes

Today SBUX does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our analysis reads Fair vs our fair value, as of 19 Nov 2026: it trades above our $96.22 fair value estimate.

Model construction and limits: fair-value methodology.

73.80Conservative96.22Base case110.65Growth case 104.47Price

Fair value range in USD, drawn from the 2026-11-19 screen. The gold marker is the market price at the same screen. The price runs 8.6% above the base estimate.

The Street's Range
82.00Street low 110.50Street average 141.00Street high 104.47Price

Third-party analyst targets: 30 covering, consensus Buy. The average target sits +6% from the screen price.

Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.

Price History & Projections

Where our models see it going: fair-value estimate $96.22, with a range of $73.80 to $110.65, dated to the 2026-11-19 screen.

How our estimate and third-party targets differ.

The Business, in Plain Words
The fundamentals · plain-English read
Forward P/E29.5xa premium valuation
Trailing P/E49.8xexpensive: the price assumes strong growth ahead
EPS, trailing2.21
EPS, forward3.72
Revenue growth-4.5%revenue is shrinking
Profit margin6.7%thin but positive margins
FCF yield2.54%
Dividend yield2.31%
Current ratio0.76below 1: short-term bills exceed liquid assets
Beta1.01moves a little more than the market
Short interest, float0.04%
52-week range81.97 - 111.50
Market cap$125.4B
Employees381,000

Metric definitions and interpretation rules: ticker-page methodology.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-19 Markup $109.11 -0.7% Entry 25

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 11%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (33 analysts) rates it buy, with a mean price target of $107. Insiders have been net sellers over the past quarter.

2026-11-12 Markup · changed $109.89 +0.2% Entry 24

The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 0.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 11%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (33 analysts) rates it buy, with a mean price target of $107. Insiders have been net sellers over the past quarter. Since the last review it entered the Titan Ethical 500.

2026-11-05 Accumulation $109.70 +8.8% Entry 23

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 8.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 11%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (33 analysts) rates it buy, with a mean price target of $107. Insiders have been net sellers over the past quarter. Since the last review it dropped out of the Titan Ethical 500.

2026-10-29 Accumulation $100.80 +4.0% Entry 22

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 4.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 11%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (33 analysts) rates it buy, with a mean price target of $107. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-28 Accumulation $96.88 +0.0% Entry 21

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 11%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (33 analysts) rates it buy, with a mean price target of $107. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-27 Accumulation $96.88 +0.0% Entry 20

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 11%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (33 analysts) rates it buy, with a mean price target of $107. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-26 Accumulation $96.88 +0.0% Entry 19

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 11%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (33 analysts) rates it buy, with a mean price target of $107. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-25 Accumulation $96.88 +0.0% Entry 18

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 11%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (33 analysts) rates it buy, with a mean price target of $107. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-24 Accumulation $96.88 +0.0% Entry 17

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 11%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (33 analysts) rates it buy, with a mean price target of $107. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-23 Accumulation $96.88 +0.0% Entry 16

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 11%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (33 analysts) rates it buy, with a mean price target of $107. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on SBUX

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in SBUX's Space

Screened names in the same industry · explore each on its own page.

The Insider Ledger · Form 4 Filings, As Filed
Most recent filings · SBUX
DateInsiderTitleTypeSharesValue
2026-11-05 Brewer Brady ceo, International S - Sale 2,229 $245,190
2026-10-20 Brewer Brady ceo, International S - Sale 588 $58,800
2026-10-05 Brewer Brady ceo, International S - Sale 1,641 $155,501
2026-05-05 Brewer Brady ceo, International Sale 2,229 $233,621
2026-04-29 Kelly Sara evp, chief partner officer Sale 2,000 $210,000
2026-04-17 Brewer Brady ceo, International Sale 588 $58,800
2026-04-06 Brewer Brady ceo, International Sale 1,641 $147,690
2026-03-09 Brewer Brady ceo, International Sale 588 $58,800
2026-03-05 Kelly Sara evp, chief partner officer Sale 2,500 $242,800
2026-03-05 Brewer Brady ceo, International Sale 1,641 $159,374

Public filings, recorded as found. The full tape lives at Insider Intelligence.

The Political Ledger · Congressional Disclosures
Disclosures naming SBUX
DatePoliticianPartyTypeAmount
2026-10-02 Pete Sessions Republican sell 15K–50K
2026-10-02 Pete Sessions Republican sell 15K–50K
2026-10-02 Pete Sessions Republican sell 15K–50K
2026-09-25 Ro Khanna Democrat sell 1K–15K
2026-09-25 Ro Khanna Democrat sell 1K–15K
What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $105.12 -6.1% $0.62 $945 -5.5%
2 months $96.04 +2.8% $0.62 $1,035 +3.5%
3 months $99.60 -0.8% $0.62 $998 -0.2%
6 months $83.71 +18.0% $1.24 $1,195 +19.5%
1 year $89.08 +10.9% $2.47 $1,136 +13.6%
2 years $77.57 +27.3% $4.87 $1,336 +33.6%
3 years $90.88 +8.7% $7.11 $1,165 +16.5%
5 years $100.17 -1.4% $11.11 $1,097 +9.7%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever SBUX does next, these words stay.

Starbucks · SBUX · Markup · $104.47
Recorded 2026-11-19 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.